Inventor
WEI JIANMEI
US39 patents
⚠️ This page may combine multiple inventors who share the name “WEI JIANMEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORTHO MCNEIL PHARM INC
15 patentsUS7309703B2Dec 18, 2007
Substituted pyrazoles
ORTHO MCNEIL PHARM INC15 citations92
US6949540B2Sep 27, 2005
Substituted pyrazoles
ORTHO MCNEIL PHARM INC13 citations92
US6583155B2Jun 24, 2003
Method for treating allergies using substituted pyrazoles
ORTHO MCNEIL PHARM INC15 citations92
US6803362B2Oct 12, 2004
Heterocyclic compounds
ORTHO MCNEIL PHARM INC38 citations91
US7772236B2Aug 10, 2010
Substituted pyrazoles
ORTHO MCNEIL PHARM INC9 citations84
US7265102B2Sep 4, 2007
Substituted pyrazoles
ORTHO MCNEIL PHARM INC9 citations74
US6936603B2Aug 30, 2005
Substituted pyrazoles
ORTHO MCNEIL PHARM INC7 citations74
US7393850B2Jul 1, 2008
Substituted pyrazoles
ORTHO MCNEIL PHARM INC3 citations73
US6953793B2Oct 11, 2005
Substituted pyrazoles
ORTHO MCNEIL PHARM INC11 citations73
US6579896B2Jun 17, 2003
Method for treating allergies using substituted pyrazoles
ORTHO MCNEIL PHARM INC5 citations72
US7417046B2Aug 26, 2008
Substituted pyrazoles
ORTHO MCNEIL PHARM INC1 citations62
US7589202B2Sep 15, 2009
Substituted pyrazoles
ORTHO MCNEIL PHARM INC0 citations52
US7452890B2Nov 18, 2008
Substituted pyrazoles
ORTHO MCNEIL PHARM INC0 citations52
US7429591B2Sep 30, 2008
Substituted pyrazoles
ORTHO MCNEIL PHARM INC0 citations52
US7388011B2Jun 17, 2008
Substituted pyrazoles
ORTHO MCNEIL PHARM INC0 citations52
JANSSEN PHARMACEUTICA NV
15 patentsUS7226938B2Jun 5, 2007
Heterocyclic compounds
JANSSEN PHARMACEUTICA NV30 citations92
US10717745B2Jul 21, 2020
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV5 citations82
US7332494B2Feb 19, 2008
Method for treating allergies using substituted pyrazoles
JANSSEN PHARMACEUTICA NV7 citations73
US12065446B2Aug 20, 2024
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV1 citations72
US11319329B2May 3, 2022
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV1 citations72
US10947252B2Mar 16, 2021
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV3 citations71
US10934310B2Mar 2, 2021
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV4 citations71
US11897900B2Feb 13, 2024
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV0 citations60
US11427601B1Aug 30, 2022
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV0 citations60
US8686142B2Apr 1, 2014
2-aminopyrimidine modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV0 citations51
US10822348B2Nov 3, 2020
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV0 citations50
US10800792B2Oct 13, 2020
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV0 citations50
US10689396B2Jun 23, 2020
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV0 citations50
US9732087B2Aug 15, 2017
Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV0 citations49
US10172856B2Jan 8, 2019
2,4-diaminopyrimidine derivatives as histamine H4 modulators
JANSSEN PHARMACEUTICA NV0 citations41
BRISTOL MYERS SQUIBB CO
3 patentsUS5808102ASep 15, 1998
Phosphorus bearing taxanes intermediates
BRISTOL MYERS SQUIBB CO24 citations92
US6515151B1Feb 4, 2003
Method for the preparation of novel sidechain-bearing taxanes and intermediates thereof
BRISTOL MYERS SQUIBB CO10 citations73
US6215000B1Apr 10, 2001
Crystalline complexes of baccatin III with imidazole, 2-methylimidazole or isopropanol
BRISTOL MYERS SQUIBB CO0 citations39